Search clinical trials for: Levonorgestrel/Ethinyl Estradiol

Total 1993 results

University of Southern California

Terminated

Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics

HIV | Contraception

United States
Duramed Research

Withdrawn

Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

Osteopenia
Oregon Health and Science University
National Institutes of Health (NIH); Oregon Clinical and Translational Research...

Completed

Oral Contraceptive Efficacy and Body Weight

Body Weight | Contraception

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
Regenex Pharmaceutical, China

Unknown

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

Oral Contraceptive

China
Janssen-Cilag International NV

Completed

A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants

Healthy

Belgium
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Therapeutic Equivalency

India
Agile Therapeutics

Completed

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

Ovulation Suppression

United States
Oregon Health and Science University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Oral Contraceptives and Body Mass Index

Body Weight | Contraceptive Usage

United States
Johns Hopkins University
Society of Family Planning

Withdrawn

Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery

Contraception | Bariatric Surgery Candidate

United States
IVI Madrid

Completed

Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients

Infertility

Spain
AbbVie

Recruiting

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Hematologic Malignancies

United States, Australia
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Menstruation Disturbances | Premenstrual Syndrome

United States, Canada
University of Saskatchewan
Canadian Institutes of Health Research (CIHR)

Completed

Human Ovarian Follicular Dynamics and Emergency Contraception

Contraception

Canada
University of Colorado, Denver

Recruiting

Contraceptive Hormone and Reward Measurement (CHARM Study) (CHARM)

Mood | Oral Hormonal Contraceptive Use | Neural Activity | Hedonic Function

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

Premenstrual Syndrome

United States
Population Council
United States Agency for International Development (USAID)

Completed

Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive

Contraception

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

Contraception
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

Menstruation Disturbances | Premenstrual Syndrome

Poland, United Kingdom, Germany, Argentina, Mexico, Romania, Netherlands, Finland, Chile, Brazil, Sweden, Denmark
Eunice Kennedy Shriver National Institute of Child...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Hormonal Birth Control and the Risk of Acquiring HIV

HIV Infections

United States
Duramed Research

Completed

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Bone Mineral Density

United States
Organon and Co

Completed

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

Contraception
HRA Pharma

Completed

Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

Emergency Contraception

Sweden, Netherlands, United Kingdom
Incyte Corporation

Recruiting

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

Healthy Participants

United States
Organon and Co

Terminated

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)

Contraception

South Africa, Austria, Costa Rica, Denmark, Finland, Germany, Hungary, Italy, Mexico, Netherlands, Norway, Peru, Poland, Sweden
Biogen

Completed

A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen

Drug Interactions

United States
Proteostasis Therapeutics, Inc.

Completed

Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers

Healthy Volunteer

United States
Teva Women's Health

Completed

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Pregnancy Prevention

United States
Duramed Research

Completed

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Breakthrough Bleeding

United States
Duramed Research

Completed

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

Contraception

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

Contraception
Oregon Health and Science University
Medical Research Foundation, Oregon

Completed

Relationship Between the Menstrual Cycle and Heart Disease in Women

Coronary Heart Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception

Oral Contraceptive
AstraZeneca
Eli Lilly and Company

Completed

The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

Type 2 Diabetes Mellitus

United Kingdom
Eli Lilly and Company
AstraZeneca

Withdrawn

A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

Healthy

Singapore
AstraZeneca

Completed

AZD6140 Oral Contraceptive Interaction Study

Healthy

United States
Pfizer

Completed

Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids

Healthy

United States
University of Arizona
Organon

Not yet recruiting

Control of Bleeding on Nexplanon in Latinx Patients

Contraception
Duramed Research

Completed

A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

Healthy

United States
Novo Nordisk A/S

Recruiting

A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.

Healthy Volunteers (Non-alcoholic Steatohepatitis)

Austria
Ain Shams Maternity Hospital

Unknown

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri (LNG-IUDvsCOCs)

Adenomyosis

Egypt
Galeno Desenvolvimento de Pesquisas Clínicas
Biolab Sanus Farmaceutica

Completed

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

Contraception

Brazil
FHI 360
La Asociación Pro Bienestar de la Familia de Guatemala (APROFAM)

Completed

Continuous Use of COCs

Pregnancy Prevention

Dominican Republic, Nicaragua
Oregon Health and Science University

Completed

A Study of Continuous Oral Contraceptives and Doxycycline

Contraceptives, Oral

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Oral Contraceptive | Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size

United States
Concert Pharmaceuticals
Celerion

Completed

Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

Healthy Volunteers

United States
Pfizer

Completed

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

Healthy Female Volunteers

United States
Boehringer Ingelheim

Completed

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

Healthy

Germany

3

Subscribe